Exploratory analysis of the key role of immune function changes in BPD

Tianyi Wu1,2,3,4, Xingmeng Fu1,2,3,4, Xiaoxia Gong1,2,3,4

  • 1Department of Respiratory Children's Hospital of Chongqing Medical University Chongqing China.

Pediatric Discovery
|July 8, 2025
PubMed

Insights

This study identifies four key genes (Cd3e, Cd3g, Cd247, Itk) and the T cell receptor signaling pathway as crucial in bronchopulmonary dysplasia (BPD). Their downregulation impairs immune function and worsens lung inflammation in premature infants.

Area of Science:

  • Neonatal Medicine
  • Pulmonology
  • Immunology

Background:

  • Bronchopulmonary dysplasia (BPD) is a severe chronic lung disease affecting premature infants.
  • Understanding the molecular mechanisms underlying BPD is critical for developing effective treatments.

Purpose of the Study:

  • To identify key genes and signaling pathways associated with BPD through transcriptomic analysis.
  • To validate these findings in both human patient data and an animal model.

Main Methods:

  • Transcriptomic analysis of Gene Expression Omnibus (GEO) dataset (GSE32472) from infants with and without BPD.
  • Bioinformatic analyses including Gene Ontology, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, protein-protein interaction, and Gene Set Enrichment Analysis (GSEA).
  • Transcriptome sequencing and quantitative polymerase chain reaction (qPCR) validation in a hyperoxia-induced rat model of BPD.

Main Results:

  • Four hub genes (Cd3e, Cd3g, Cd247, Itk) and the T cell receptor signaling pathway were identified as significantly associated with BPD.
  • Downregulation of these genes and pathway was observed in BPD patients and the animal model.
  • Reduced T cell receptor signaling function correlates with immune dysfunction, increased lung inflammation, and susceptibility to infections in BPD.

Conclusions:

  • The identified genes and T cell receptor signaling pathway play a critical role in the pathogenesis of BPD.
  • Targeting these pathways may offer therapeutic strategies to mitigate BPD severity and associated complications.